首页|期刊导航|Bone Research|Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects
Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects
Zhenqiang Yao Akram Ayoub Venkatesan Srinivasan Jun Wu Churou Tang Rong Duan Aleksa Milosavljevic Lianping Xing Frank H.Ebetino Alison J.Frontier Brendan F.Boyce
Bone Research2024,Vol.12Issue(3):P.734-744,11.
Bone Research2024,Vol.12Issue(3):P.734-744,11.DOI:10.1038/s41413-024-00352-6
Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects
摘要
关键词
res/conjugate/phosphonate分类
医药卫生引用本文复制引用
Zhenqiang Yao,Akram Ayoub,Venkatesan Srinivasan,Jun Wu,Churou Tang,Rong Duan,Aleksa Milosavljevic,Lianping Xing,Frank H.Ebetino,Alison J.Frontier,Brendan F.Boyce..Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects[J].Bone Research,2024,12(3):P.734-744,11.基金项目
funded by National Institutes of Health,National Institute on Aging,grant numbers,R01AG076731,R01AG049994 ()
National Institute for Arthritis and Musculoskeletal and Skin Diseases,R01AR043510,and P30 AR069655。 ()